K161277 is an FDA 510(k) clearance for the ConvertX Nephroureteral Stent System. Classified as Stent, Ureteral (product code FAD), Class II - Special Controls.
Submitted by Brightwater Medical (Dunlap, US). The FDA issued a Cleared decision on November 22, 2016 after a review of 200 days - an extended review cycle.
This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.4620 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.